Free Trial

Procter & Gamble (NYSE:PG) Shares Up 0.6% - What's Next?

Procter & Gamble logo with Consumer Staples background

The Procter & Gamble Company (NYSE:PG - Get Free Report)'s share price traded up 0.6% during trading on Monday . The company traded as high as $172.78 and last traded at $172.09. 1,317,898 shares changed hands during mid-day trading, a decline of 80% from the average session volume of 6,664,009 shares. The stock had previously closed at $171.06.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. Evercore ISI increased their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an "outperform" rating in a research report on Monday, October 21st. Royal Bank of Canada restated a "sector perform" rating and set a $164.00 price objective on shares of Procter & Gamble in a research note on Monday, October 21st. Wells Fargo & Company boosted their target price on shares of Procter & Gamble from $188.00 to $190.00 and gave the company an "overweight" rating in a research report on Friday, November 22nd. DZ Bank raised Procter & Gamble from a "hold" rating to a "buy" rating and set a $190.00 price target on the stock in a research report on Thursday, August 29th. Finally, Wolfe Research raised Procter & Gamble to a "strong-buy" rating in a report on Friday, August 23rd. Eight equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Procter & Gamble currently has a consensus rating of "Moderate Buy" and a consensus price target of $180.45.

Check Out Our Latest Research Report on PG

Procter & Gamble Stock Performance

The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The firm has a market cap of $403.04 billion, a PE ratio of 29.51, a P/E/G ratio of 3.70 and a beta of 0.44. The firm has a 50-day moving average price of $170.82 and a two-hundred day moving average price of $169.71.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to analysts' expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm's quarterly revenue was down .6% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.83 EPS. Research analysts forecast that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were issued a $1.0065 dividend. The ex-dividend date was Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.35%. Procter & Gamble's dividend payout ratio is presently 69.31%.

Insider Buying and Selling

In other news, CEO Jon R. Moeller sold 7,007 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the sale, the chief executive officer now owns 269,172 shares of the company's stock, valued at approximately $46,203,373.80. The trade was a 2.54 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Gary A. Coombe sold 47,847 shares of the company's stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the transaction, the chief executive officer now directly owns 39,977 shares in the company, valued at approximately $7,189,463.68. This trade represents a 54.48 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 83,080 shares of company stock worth $14,629,038. 0.18% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Procter & Gamble

A number of institutional investors have recently modified their holdings of PG. Colonial River Wealth Management LLC increased its stake in shares of Procter & Gamble by 1.2% during the second quarter. Colonial River Wealth Management LLC now owns 8,024 shares of the company's stock worth $1,323,000 after buying an additional 96 shares during the period. M3 Advisory Group LLC raised its position in shares of Procter & Gamble by 4.8% during the 2nd quarter. M3 Advisory Group LLC now owns 3,177 shares of the company's stock worth $524,000 after acquiring an additional 146 shares in the last quarter. Pallas Capital Advisors LLC lifted its stake in Procter & Gamble by 2.4% during the second quarter. Pallas Capital Advisors LLC now owns 92,099 shares of the company's stock worth $15,513,000 after purchasing an additional 2,168 shares during the last quarter. Sunpointe LLC grew its position in shares of Procter & Gamble by 7.3% in the 2nd quarter. Sunpointe LLC now owns 2,800 shares of the company's stock valued at $462,000 after buying an additional 191 shares during the last quarter. Finally, Cidel Asset Management Inc. raised its stake in Procter & Gamble by 3.6% during the 2nd quarter. Cidel Asset Management Inc. now owns 76,204 shares of the company's stock worth $12,568,000 after acquiring an additional 2,615 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Read More

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines